ID
35332
Descrição
Study ID: 101222 Clinical Study ID: 101222 Study Title: Study to demonstrate the non-inferiority of GSK Biologicals' DTPw-HBV/Hib Kft. vaccine compared to GSK Biologicals' Tritanrix™-HepB/Hiberix™ vaccine and to separate administration of DTPw-HBV Kft. and Hiberix™ vaccines with respect to the immunogenicity of all antigens, when administered to healthy infants. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Combined Diphtheria, Tetanus, Whole Cell Pertussis, Hepatitis B, Haemophilus influenzae Type b Vaccine (KFT) Trade Name:Zilbrix/Hib Study Indication: Diphtheria; Haemophilus influenzae type b; Hepatitis B; Tetanus; Whole Cell Pertussis
Palavras-chave
Versões (2)
- 27/02/2019 27/02/2019 -
- 28/02/2019 28/02/2019 -
Titular dos direitos
GSK group of companies
Transferido a
28 de fevereiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Immunogenicity of TPw-HBV/Hib Kft. Vaccine in healthy infants - 101222
VISIT 1 (Day 0 Birth)
- StudyEvent: ODM
Descrição
CONTRAINDICATIONS TO SUBSEQUENT VACCINATION
Descrição
The following adverse events (AEs) constitute absolute contraindications to further administration of the study vaccines; if any of these AEs occur during the study, the subject must not receive additional doses of vaccine but may continue other study procedures at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE :
Tipo de dados
boolean
Descrição
hypersensitivity to vaccine
Tipo de dados
boolean
Descrição
This is defined as an acute, severe central nervous system disorder occurring within 7 days following vaccination, and generally consisting of major alterations in consciousness, unresponsiveness, generalized or focal seizures that persist more than a few hours, with failure to recover within 24 hours. Even though causation by DTP vaccine cannot be established, no subsequent doses of pertussis vaccine should be given. In these circumstances the vaccination course should be continued with DT and HB vaccines.
Tipo de dados
boolean
Descrição
The following AEs constitute contraindications to administration of the study vaccines at that point in time; if any one of these AEs occurs at the time scheduled for vaccination, the subject may be vaccinated at a later date, within the time window specified in the protocol, or withdrawn at the discretion of the investigator. The subject must be followed until resolution of the event, as with any AE.
Tipo de dados
boolean
Descrição
Temperature
Tipo de dados
boolean
Descrição
PRECAUTIONS
Descrição
If any of the following events occur in temporal relation to receipt of study vaccines, the decision to give subsequent doses of vaccine containing the pertussis component should be carefully considered.
Tipo de dados
boolean
Descrição
Collapse or Shock
Tipo de dados
boolean
Descrição
Crying
Tipo de dados
boolean
Descrição
A history of febrile convulsions, a family history of convulsions, a family history of Sudden Infant Death Syndrome (SIDS) and a family history of an adverse event following TritanrixTM-HepB vaccination do not constitute contraindications.
Tipo de dados
boolean
Descrição
Reminder
Tipo de dados
text
Descrição
INFORMED CONSENT
Descrição
DEMOGRAPHICS
Descrição
Center number
Tipo de dados
integer
Descrição
Date of birth
Tipo de dados
date
Descrição
Gender
Tipo de dados
text
Descrição
Race
Tipo de dados
text
Descrição
ELIGIBILITY CHECK
Descrição
INCLUSION CRITERIA
Descrição
Tick the boxes corresponding to any of the inclusion criteria the subject failed
Tipo de dados
boolean
Descrição
Tick the boxes corresponding to any of the inclusion criteria the subject failed
Tipo de dados
boolean
Descrição
Tick the boxes corresponding to any of the inclusion criteria the subject failed
Tipo de dados
boolean
Descrição
Tick the boxes corresponding to any of the inclusion criteria the subject failed
Tipo de dados
boolean
Descrição
Tick the boxes corresponding to any of the inclusion criteria the subject failed
Tipo de dados
boolean
Descrição
Tick the boxes corresponding to any of the inclusion criteria the subject failed
Tipo de dados
boolean
Descrição
EXCLUSION CRITERIA
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
Tick the box corresponding to any of the exclusion criteria that disqualified the subject from entry.
Tipo de dados
boolean
Descrição
RANDOMISATION / TREATMENT ALLOCATION
Descrição
GROUP HBV AT BIRTH
Similar models
VISIT 1 (Day 0 Birth)
- StudyEvent: ODM